SALLY DECASTRO-TILSEN: Open Payments
NPI 1023282019 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,166 in 295 payments from 28 companies in 2025. Trend: 2023 $17,359 · 2024 $11,182 · 2025 $8,166
Food & beverage: $8,082Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 86 | $1,947 |
| UCB, Inc. | 49 | $1,415 |
| Axsome Therapeutics, Inc. | 37 | $690 |
| PFIZER INC. | 27 | $683 |
| Lundbeck LLC | 11 | $482 |
| Teva Pharmaceuticals USA, Inc. | 9 | $374 |
| Neurocrine BioSciences, Inc. | 13 | $365 |
| Eisai Inc. | 7 | $267 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $245 |
| Alkermes, Inc. | 2 | $242 |
Products named: Rystiggo, BOTOX, NURTEC ODT, QULIPTA, Auvelity, VYEPTI, INGREZZA, Leqembi.
Industry payments across CA — which companies pay providers there.
